SUH CAROL Y. (Chief Operating Officer) received a stock award from NEUMORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2024ACC: 0001610717-24-000067
Officer· Chief Operating Officer
Since Sep 2023
+255K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
255K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+85K
Price / share
—
Trade value
—
% of position
29.3%
2/14/2024
289.67K→374.67K
Total
Net shares
+85K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2024 | A · Award | +85K | — | — | 29.3% | 289.67K | 374.67K |
| Total | +85K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
170K shares
Shares
+170K
Strike price
18.07
Held after
170K
Exercisable
—
2/14/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock170K shares | 2/14/2024 | A · Award | +170K | 18.07 | — | 170K |